Connect your AI

Boston Scientific BSX Pre-Judgement Interest

Other financials

Income statement

Revenue$5.2B+11.6%

Gross profit$3.6B+12.6%

Operating income$1.1B+19.5%

Net income$1.3B+99.3%

EPS (diluted)$0.90+100%

Balance sheet

Cash & equivalents$850.0M+146%

Total equity$25.9B+16.4%

Total assets$44.4B+10.5%

Cash flow

Operating cash flow$348.0M-35.7%

CapEx$177.0M-5.4%

Free cash flow$171.0M-51.7%

Valuation

Market cap$67.32B-37.5%

P/E18.9×-34.3×

P/S3.3×-2.9×

Profitability

Gross margin69.2%+0.5pp

Operating margin18.4%+2.2pp

Net margin17.3%+5.7pp

Returns & leverage

Return on equity14.8%+5.2pp

Debt / equity0×-0.5×

Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept bsx:PreJudgementInterest.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's pre-judgement interest.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Boston Scientific's pre-judgement interest?: Boston Scientific (BSX) reported pre-judgement interest of $7M in Q2 2024.